American Society of Hematology (ASH) 61st Annual Meeting: Orlando, FL, USA, 6–10 December 2019 Martin Chopra Meeting Report 29 January 2020 Pages: 1 - 6
2019 San Antonio Breast Cancer Symposium: San Antonio, TX, USA, 10–14 December 2019 Martin Chopra Meeting Report 25 January 2020 Pages: 7 - 9
Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond Romain CohenBenoît RousseauThierry André Review Article 30 November 2019 Pages: 11 - 24
Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review Michele PorcuCinzia SolinasLuca Saba Review Article 11 January 2020 Pages: 25 - 35
BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta-Analysis Lorena Alves TeixeiraFrancisco Jose Candido dos Reis Systematic Review 20 January 2020 Pages: 37 - 46
Association Between Glutathione-S-Transferase Gene Polymorphisms and Responses to Tyrosine Kinase Inhibitor Treatment in Patients with Chronic Myeloid Leukemia: A Meta-analysis Nari LeeSu Min ParkHye Sun Gwak Systematic Review 23 January 2020 Pages: 47 - 54
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer Todd M. BauerAlice T. ShawEnriqueta Felip Original Research Article Open access 14 February 2020 Pages: 55 - 65
Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study Seung Tae KimJung Yong HongYoung Suk Park Original Research Article 09 December 2019 Pages: 67 - 73
Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study Hidenori KatoPaul de SouzaYung-Jue Bang Original Research Article Open access 07 February 2020 Pages: 75 - 84
Phase I Study of Irinotecan/5-Fluorouracil/Leucovorin (FOLFIRI) with Sunitinib for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Sarbajit MukherjeeChristos FountzilasRenuka Iyer Original Research Article 04 December 2019 Pages: 85 - 92
Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer Di HuangFan ZhangYi Hu Original Research Article 12 February 2020 Pages: 93 - 100
Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy Magdalena OlbrytWojciech PigłowskiAnna Fiszer-Kierzkowska Original Research Article Open access 25 January 2020 Pages: 101 - 113
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study Luca FaloppiMarco PuzzoniMario Scartozzi Original Research Article 04 February 2020 Pages: 115 - 126
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities Ioannis A. Voutsadakis Original Research Article 18 November 2019 Pages: 127 - 138
c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis Valentin Van den BosscheGaspard JadotEmmanuel Seront Therapy in Practice 04 February 2020 Pages: 139 - 146